Delhi court rejects Bayer injunction against Natco Pharma generic

18-07-2019

Saman Javed

Delhi court rejects Bayer injunction against Natco Pharma generic

photobyphm / Shutterstock.com

India’s Delhi High Court has dismissed a petition for an injunction by German pharma company Bayer against an Indian competitor.


Natco Pharma, Bayer, India Delhi High Court, patent infringement, generics, colorectal cancer, Regorafenib

LSIPR